For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.
How has increasing demand for OSA treatment and new technology changed OSA management at European sleep centers over the past decade?
Researchers sought to establish a minimal empirically supported level of accuracy for a classifier to be clinically useful in an Adaptive Treatment Strategy and explore the relative value of input predictors.
A total of 1055 individuals with children aged 6-12 years consented to participate in this study. Participants underwent a structured interview about symptoms of ADHD and sleep disturbances of their child in 3 waves.
Researchers sought to assess sleep quality in relation to PrEP adherence among younger Black sexual minority men.
Researchers sought to assess OSA symptoms and age of OSA diagnosis in children with and without ASD.
A study of sarcoidosis assessed the extent to which increasing BMI and obstructive sleep apnea were associated with disease development.
In a Mendelian randomization, researchers evaluated whether a causal genetic relationship exists between OSA and AD or PD.
Are patients with asthma and allergic rhinitis who initiate montelukast at higher risk for sleep and anxiety disorders?
This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.
